Armen R. Kherlopian

Armen R. Kherlopian, Ph.D., is the Chief Executive Officer and Partner at Covenant Venture Capital and also serves as the Chief Science and Innovation Officer. Kherlopian is a Scientific Advisory Board Member at the Translational Research Institute for Space Health, focusing on astronaut health for future deep space missions. Additional roles include Board Director at Scylla, Co-Founder of Voxface, and Founding Partner at BAJ Accelerator. Kherlopian provides advisory services to multiple companies, including Bitvore, Embodied, Inc., cognaize, and New Health Investment Group. As an investor with New York Angels, Kherlopian leverages a strong educational background with a PhD in Biophysics from Cornell University and advanced degrees in Biomedical Engineering from Columbia Engineering.